EAGLE PHARMACEUTICALS, INC. Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EAGLE PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EAGLE PHARMACEUTICALS, INC. for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Payment of Exercise | F | 57.98 | 7,548 | 437,633 | 1,550,954 | 1.6 M to 1.6 M (-0.48 %) |
| Jan 27 2020 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Payment of Exercise | F | 57.98 | 1,793 | 103,958 | 49,811 | 51.6 K to 49.8 K (-3.47 %) |
| Jan 27 2020 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Payment of Exercise | F | 57.98 | 1,630 | 94,507 | 48,784 | 50.4 K to 48.8 K (-3.23 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 59.80 | 145,700 | 8,712,132 | 145,700 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Grant | A | 0.00 | 58,300 | 0 | 1,558,502 | 1.5 M to 1.6 M (+3.89 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Simpson Jennifer K. | Director | Option Exercise | A | 59.80 | 10,000 | 597,950 | 10,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | RATOFF STEVEN B | Director | Option Exercise | A | 59.80 | 10,000 | 597,950 | 10,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Option Exercise | A | 59.80 | 51,000 | 3,049,545 | 51,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Payment of Exercise | F | 57.38 | 904 | 51,872 | 51,604 | 52.5 K to 51.6 K (-1.72 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Grant | A | 0.00 | 21,500 | 0 | 52,508 | 31 K to 52.5 K (+69.34 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 59.80 | 48,000 | 2,870,160 | 48,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Payment of Exercise | F | 57.38 | 632 | 36,264 | 45,268 | 45.9 K to 45.3 K (-1.38 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 19,500 | 0 | 45,900 | 26.4 K to 45.9 K (+73.86 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Option Exercise | A | 59.80 | 55,000 | 3,288,725 | 55,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Payment of Exercise | F | 57.38 | 815 | 46,765 | 50,414 | 51.2 K to 50.4 K (-1.59 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Grant | A | 0.00 | 24,000 | 0 | 51,229 | 27.2 K to 51.2 K (+88.14 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Graves Michael | Director | Option Exercise | A | 59.80 | 10,000 | 597,950 | 10,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Glenning Robert | Director | Option Exercise | A | 59.80 | 10,000 | 597,950 | 10,000 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Edlin Richard A. | Director | Option Exercise | A | 59.80 | 10,000 | 597,950 | 10,000 |